Can a smartphone app tame Alcohol-Related liver disease?

NCT ID NCT06319222

First seen Aug 07, 2026 ยท Last updated Aug 07, 2026

Summary

This trial tests whether a digital clinic, delivered through a smartphone app, can improve health outcomes for people with alcohol-associated liver disease (ALD) and alcohol use disorder (AUD). Participants' doctors are randomly assigned to refer them to this digital platform in addition to standard care, or to provide standard care alone. The study tracks liver health, alcohol abstinence, and hospitalizations to see if the digital approach helps.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
A digital clinic delivered via a smartphone app (RTP application) for managing alcohol-associated liver disease and alcohol use disorder
What this could lead to
If successful, this digital clinic could offer a scalable, accessible way to improve liver health and support alcohol abstinence, potentially reducing hospitalizations and healthcare costs.
What could go wrong
This is a relatively small trial, and the digital approach may not work for everyone. Success depends on patient engagement and technology adoption, and results may not generalize to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Mayo Clinic Arizona

    Scottsdale, Arizona, 85259, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.